These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
178 related items for PubMed ID: 28641336
1. Suppression of Forkhead Box Protein O1 (FOXO1) Transcription Factor May Promote Adrenocortical Tumorigenesis. Stenman A, Murtha T, Korah R, Carling T. Horm Metab Res; 2017 Aug; 49(8):631-637. PubMed ID: 28641336 [Abstract] [Full Text] [Related]
2. A novel FOXO1-mediated dedifferentiation blocking role for DKK3 in adrenocortical carcinogenesis. Cheng JY, Brown TC, Murtha TD, Stenman A, Juhlin CC, Larsson C, Healy JM, Prasad ML, Knoefel WT, Krieg A, Scholl UI, Korah R, Carling T. BMC Cancer; 2017 Mar 01; 17(1):164. PubMed ID: 28249601 [Abstract] [Full Text] [Related]
3. Lower expression of ATM and gene deletion is more frequent in adrenocortical carcinomas than adrenocortical adenomas. Ye J, Qi Y, Wang W, Sun F, Wei Q, Su T, Zhou W, Jiang Y, Yuan W, Cai J, Cui B, Ning G. Endocrine; 2012 Jun 01; 41(3):479-86. PubMed ID: 22311173 [Abstract] [Full Text] [Related]
4. Survivin in adrenocortical tumors - pathophysiological implications and therapeutic potential. Sbiera S, Kroiss M, Thamm T, Beyer M, Majidi F, Kuehner D, Wobser M, Becker JC, Adam P, Ronchi C, Allolio B, Fassnacht M. Horm Metab Res; 2013 Feb 01; 45(2):137-46. PubMed ID: 23143666 [Abstract] [Full Text] [Related]
5. Livin/BIRC7 expression as malignancy marker in adrenocortical tumors. Altieri B, Sbiera S, Della Casa S, Weigand I, Wild V, Steinhauer S, Fadda G, Kocot A, Bekteshi M, Mambretti EM, Rosenwald A, Pontecorvi A, Fassnacht M, Ronchi CL. Oncotarget; 2017 Feb 07; 8(6):9323-9338. PubMed ID: 28030838 [Abstract] [Full Text] [Related]
13. Expression of FSCN1 and FOXM1 are associated with poor prognosis of adrenocortical carcinoma patients. Liang J, Liu Z, Wei X, Zhou L, Tang Y, Zhou C, Wu K, Zhang F, Zhang F, Lu Y, Zhu Y. BMC Cancer; 2019 Nov 29; 19(1):1165. PubMed ID: 31783819 [Abstract] [Full Text] [Related]
18. Telomerase and N-Cadherin Differential Importance in Adrenocortical Cancers and Adenomas. Pereira SS, Máximo V, Coelho R, Batista R, Soares P, Guerreiro SG, Sobrinho-Simões M, Monteiro MP, Pignatelli D. J Cell Biochem; 2017 Aug 29; 118(8):2064-2071. PubMed ID: 27886397 [Abstract] [Full Text] [Related]
19. Is there a role for epithelial-mesenchymal transition in adrenocortical tumors? Bulzico D, Faria PAS, Maia CB, de Paula MP, Torres DC, Ferreira GM, Pires BRB, Hassan R, Abdelhay E, Vaisman M, Vieira Neto L. Endocrine; 2017 Nov 29; 58(2):276-288. PubMed ID: 28887601 [Abstract] [Full Text] [Related]